TRAF3在Toll样受体依赖性和非依赖性抗病毒反应中的关键作用。

Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.

作者信息

Oganesyan Gagik, Saha Supriya K, Guo Beichu, He Jeannie Q, Shahangian Arash, Zarnegar Brian, Perry Andrea, Cheng Genhong

机构信息

Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, 609 Charles E. Young Dr. East, Los Angeles, California 90095, USA.

出版信息

Nature. 2006 Jan 12;439(7073):208-11. doi: 10.1038/nature04374. Epub 2005 Nov 23.

Abstract

Type I interferon (IFN) production is a critical component of the innate defence against viral infections. Viral products induce strong type I IFN responses through the activation of Toll-like receptors (TLRs) and intracellular cytoplasmic receptors such as protein kinase R (PKR). Here we demonstrate that cells lacking TRAF3, a member of the TNF receptor-associated factor family, are defective in type I IFN responses activated by several different TLRs. Furthermore, we show that TRAF3 associates with the TLR adaptors TRIF and IRAK1, as well as downstream IRF3/7 kinases TBK1 and IKK-epsilon, suggesting that TRAF3 serves as a critical link between TLR adaptors and downstream regulatory kinases important for IRF activation. In addition to TLR stimulation, we also show that TRAF3-deficient fibroblasts are defective in their type I IFN response to direct infection with vesicular stomatitis virus, indicating that TRAF3 is also an important component of TLR-independent viral recognition pathways. Our data demonstrate that TRAF3 is a major regulator of type I IFN production and the innate antiviral response.

摘要

I型干扰素(IFN)的产生是机体抵御病毒感染固有防御的关键组成部分。病毒产物通过激活Toll样受体(TLR)和细胞内胞质受体如蛋白激酶R(PKR)诱导强烈的I型干扰素反应。在此我们证明,缺乏TNF受体相关因子家族成员TRAF3的细胞,在由几种不同TLR激活的I型干扰素反应中存在缺陷。此外,我们表明TRAF3与TLR接头蛋白TRIF和IRAK1以及下游的IRF3/7激酶TBK1和IKK-ε相关联,这表明TRAF3是TLR接头蛋白与对IRF激活重要的下游调节激酶之间的关键连接。除了TLR刺激外,我们还表明,缺乏TRAF3的成纤维细胞在对水疱性口炎病毒直接感染的I型干扰素反应中存在缺陷,这表明TRAF3也是不依赖TLR的病毒识别途径的重要组成部分。我们的数据表明,TRAF3是I型干扰素产生和固有抗病毒反应的主要调节因子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索